Hotta T, Asai K, Takeda N, Tatematsu A, Nakanishi K, Eksioglu Y Z, Isobe I, Kato T
Department of Bioregulation Research, Nagoya City University Medical School, Japan.
J Neurochem. 1993 Jan;60(1):312-9. doi: 10.1111/j.1471-4159.1993.tb05853.x.
Human glioma cell extracts were found to elicit a marked growth-promoting activity on human neuroblastoma cells. This activity was also detected in the extracts of neurofibroma type 1 (NF1; von Recklinghausen neurofibromatosis) comprising aberrant Schwann cell growth. The purified substance from the NF1 extracts by HPLC on ODS columns was identical to a pyrimidine nucleoside, uridine, the chemical structure of which was identified by gas chromatography-mass spectrometry. The authentic uridine showed a strong growth-promoting activity on human neuroblastoma cells. Other purine or pyrimidine nucleotides, their derivatives, and ribose sources for their syntheses were employed to test the activity; a purine nucleoside, adenosine, showed a stronger activity than uridine. The current study raises the possibility that human neuroblastoma cells may be affected by dysfunctions of the de novo pathway of both purine and pyrimidine nucleotide biosyntheses.
研究发现,人胶质瘤细胞提取物对人神经母细胞瘤细胞具有显著的促生长活性。在1型神经纤维瘤(NF1;冯雷克林霍增氏神经纤维瘤病)提取物中也检测到了这种活性,该提取物包含异常的施万细胞生长。通过ODS柱上的高效液相色谱法从NF1提取物中纯化得到的物质与一种嘧啶核苷——尿苷相同,其化学结构通过气相色谱-质谱法得以鉴定。纯尿苷对人神经母细胞瘤细胞显示出强烈的促生长活性。使用其他嘌呤或嘧啶核苷酸、它们的衍生物以及用于合成它们的核糖来源来测试活性;一种嘌呤核苷——腺苷,显示出比尿苷更强的活性。当前的研究提出了一种可能性,即人神经母细胞瘤细胞可能受到嘌呤和嘧啶核苷酸生物合成从头途径功能障碍的影响。